Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 11, 2009, Pages 1241-1246

  Kim, Moon Young ^a   Baik, Soon Koo ^a   Yea, Chang Jin ^a   Lee, Il Young ^a   Kim, Hye Jung ^a   Park, Kyong Won ^a   Kim, Hearn Kook ^a   Suk, Ki Tae ^a   Kim, Jae Woo ^a   Kim, Hyun Soo ^a   Kwon, Sang Ok ^a   Cha, Seung Hwan ^b   Kim, Young Ju ^b   Koh, Sang Baek ^b   Chang, Sei Jin ^b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

Child Pugh score; Hepatic venous pressure gradient; Hepatocellular carcinoma; Model for End Stage Liver Disease score; Serum sodium

Indexed keywords

ALPHA FETOPROTEIN; SODIUM ION;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATIC VEIN; HUMAN; HYPONATREMIA; LIVER ANGIOGRAPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PORTAL HYPERTENSION; PREDICTOR VARIABLE; PRESSURE GRADIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VENOUS PRESSURE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; HYPONATREMIA; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; VENOUS PRESSURE;

EID: 70350161040     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832a21c1     Document Type: Article

References (22)

1. Saunders JB,Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981; 282:263-266
2. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44:217-231
3. Londono MC, Cardenas A, Guevara M, Quinto L, de Las Heras D, Navasa M, et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007; 56:1283-1290
4. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40:802-810
5. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41:32-39
6. Lebrec D. Methods to evaluate portal hypertension. Gastroenterol Clin North Am 1992; 21:41-59
7. Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol 2005; 100:631-635
8. Baik SK, Kim JW, Kim HS, Kwon SO, Kim YJ, Park JW, et al. Recent variceal bleeding: doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006; 240:574-580
9. Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut 1987; 28:260-266
10. Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int 2007; 27:1103-1110
11. Baik SK, Park DH, Kim MY, Choi YJ, Kim HS, Lee DK, et al. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity. J Gastroenterol 2003; 38:1150-1154
12. Baik SK, Jee MG, Jeong PH, Kim JW, Ji SW, Kim HS, et al. Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis. Korean J Intern Med 2004; 19:165-170
13. Baik SK. Assessment and current treatment of portal hypertension. Korean J Hepatol 2005; 11:211-217
14. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43:167-176
15. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353:2254-2261
16. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131:1611-1624
17. Burroughs AK, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 2002; 50:425-427
18. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99:1401-1407
19. Ripoll C. Hepatic venous pressure gradient and outcomes in cirrhosis. J Clin Gastroenterol 2007; 41:S330-S335
20. Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, et al. Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea. Korean J Hepatol 2008; 14:150-158
21. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111:1018-1022
22. Ripoll CGR, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independent of duration and severity of cirrhosis. Hepatology 2006; 44:245A-246A